top of page
Search


Admin
Apr 16, 20232 min read
Pipeline Therapeutics Announces a $1 Billion USD Global Licensing Deal with Janssen Pharma (J&J)
Pipeline Therapeutics and Janssen enter into a global licensing deal for PIPE-307. The deal is valued up to $1B USD.

Admin
Feb 27, 20232 min read
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership
The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech.


Admin
Jan 9, 20233 min read
Forbes: AbSci Is Using Generative AI To Design New Antibodies
bsci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly. He

Admin
Jan 30, 20222 min read
Ribbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis Technology
VIENNA, AUSTRIA, January 31, 2022 -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in...

Admin
Jan 11, 20221 min read
Merck leans into AI with $610M in biobucks for Absci drug discovery pact
VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company ...


Admin
Jul 18, 20211 min read
AbSci sets IPO terms, valuing company at up to $1.5 billion
AbSci Corp. ABSI, has set terms of its initial public offering, which could value the Washington-based provider of an artificial...

Admin
Jul 14, 20211 min read
Protein discovery and development platform AbSci sets terms for $200 million IPO
AbSci, which provides a platform for the discovery and development of proteins and biologics, announced terms for its IPO on Thursday....


Admin
Jul 12, 20212 min read
Helicase Venture portfolio company Absci files for IPO
https://seekingalpha.com/news/3711566-biotech-discovery-company-absci-files-for-ipo Absci Corp., a synthetic biology company whose...


Admin
Jun 13, 20213 min read
Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor
https://www.globenewswire.com/news-release/2021/06/14/2246385/0/en/Landos-Biopharma-Announces-Positive-Outcome-of-End-of-Phase-2-Meeting-...


Admin
Jun 13, 20212 min read
Totient, a Helicase Venture Portfolio Company, has been Acquired by AbSci
Totient, a Helicase Venture portfolio company, has been acquired by AbSci, a synthetic biology company unlocking the potential of...


Admin
Mar 1, 20212 min read
Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307
SAN DIEGO, March 2, 2021 – Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...


Admin
Feb 10, 20211 min read
Pipeline Therapeutics Completes Oversubscribed $80 Million Series C Financing
SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...


Admin
Jan 14, 20212 min read
Landos Biopharma guns for a $100M IPO to boost AI autoimmune R&D work
Landos is based upon the work of CEO Josep Bassaganya-Riera, Ph.D., a serial entrepreneur and Virginia Tech professor who outlined the...


Admin
Jul 22, 20203 min read
Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss
PIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with ...
bottom of page